Is Viking Therapeutics Stock Going to $50? Bulls and Bears
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Biotech Investing
On this Biotech Investing tag page, 5 recent articles cover innovative biotech stocks, Agios moves, Arcellx updates, Cogent Biosciences and more, giving you quick, actionable finance insights.
109 articlesArcutis Vertex: Which Pharmaceutical Stock Is Better in 2026
In 2026, investors face a classic showdown: a rapid-growth dermatology
Revolution Medicines Billion Market: Why the Valuation Makes Sense
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
Is Viking Therapeutics Stock Going to $100? Realistic Analysis
Investors are weighing big potential against real-world risk. This article breaks down VK2735, market dynamics, and w...
Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Nuvation Stock 190% Despite: Insider Sale Insights for Investors
Nuvation Bio has surged, even as an insider sold a meaningful stake. This piece breaks down what the move means, how ...
Palantir's Bold Biosecurity Opportunity Could Boost Returns
Palantir sits at a crossroads of defense data and biotech action. This article explores why palantir's bold biosecuri...
What Know About This Palvella Insider Sale After 476K Rally
Palvella Therapeutics just saw a notable insider move after a multi-hundred percent rally. This guide breaks down the...
What Savara Investors Should Know About 580K Options
Savara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
Dyne Therapeutics vs Viking Therapeutics: 2026 Buy Guide
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Related Topics
#Stock Analysis (25)
#Earnings Analysis (22)
#Portfolio Management (15)
#Portfolio Strategy (13)
#Stock Market (12)
#Investing (10)
#Insider Trading (10)
#risk-management (8)
#Hedge Funds (7)
#Earnings (5)
#Healthcare Stocks (5)
#SEC Filings (5)
#Investment Strategy (4)
#Stock Market News (4)
#Small-Cap Stocks (4)